UKCVN Conference 2026
Welcome
Through year-round engagement – including expert discussions, working groups, and a quarterly newsletter – we engage and promote our membership. Our annual conference serves as the flagship event, bringing together key experts to discuss latest developments and provide a unique opportunity for networking.
Hosted in Oxford in 2026, the Conference takes place in the University's brand new state-of-the-art Life and Mind Building.
100%
would recommend to their colleagues
6
previous UKCVN Conferences
100%
agree the educational needs of the conference were met
148
conference attendees in 2025
Aim of the yearly UKCVN Conference
To bring together vaccine researchers, policymakers, clinicians, scientists and other professionals involved in vaccine discovery, development and delivery to share knowledge, discuss the latest advances in the field, exchange best practice and build collaborative networks.
2026 Conference Objectives
- Advance understanding of current and emerging developments in vaccine science, including novel technologies, infectious diseases, cancer immunoprevention, neurological conditions and global health.
- Explore the factors influencing vaccine confidence, acceptance, access and uptake across different populations and stages of life.
- Examine innovations in vaccine research, development and delivery, including artificial intelligence, data science, immune profiling, novel formulations and pandemic preparedness.
- Strengthen the translation of scientific evidence into effective vaccine policy, clinical practice and public-health programmes through the sharing of best practice.
- Promote multidisciplinary collaboration, professional development and global vaccine equity by supporting networking, early-career researchers and future research partnerships.
Learning Outcomes 2026
By the end of the conference, participants should be able to:
- Describe important recent developments and emerging priorities in vaccinology.
- Recognise key barriers to vaccine acceptance, access and implementation.
- Evaluate how new scientific and digital approaches may contribute to vaccine development and delivery.
- Identify opportunities to translate research findings into policy and clinical practice.
- Establish new professional connections and potential collaborations.
- Apply relevant learning from the conference within their own research, clinical, policy or public-health setting.
The 2025 UK Clinical Vaccine Network Conference in Sheffield was a highly engaging and impactful event. It brought together experts from across the UK to share insights, showcase innovation, and discuss practical approaches to vaccine research and delivery. The quality of the programme, combined with the collaborative and inclusive atmosphere, made it an excellent opportunity for learning and networking.
Rachel White, Senior Research Nurse, Oxford Vaccine Group
Please click here for the final programme
All sessions and speakers are subject to change.
Day one – Wednesday 30th Sept
|
09.30 – 10.00 |
Registration and coffee |
||
|
10.00 – 10.15 |
Welcome & opening remarks |
Professor Katrina Pollock MRC Clinician Scientist in Vaccinology, Oxford Vaccine Group Chair of UKCVN 2026 Conference Committee |
|
|
|
Session 1 - Vaccine acceptance across the life course |
||
|
10.15 – 10.35 |
Historical overview of vaccine hesitancy |
Dr Sally Frampton |
|
|
10.35 – 10.55 |
Global trends in barriers to vaccination |
Assistant Professor Alexandre de Figueiredo |
|
|
10.55 – 11.15 |
Parental views and experiences with vaccination |
Dr Helen Campbell |
|
|
11.15 – 11.45 |
Coffee Break |
||
|
|
Session 2 - Vaccines for Neurological Diseases |
||
|
11.45 – 12.05 |
EBV vaccines and multiple sclerosis |
Professor Dave Hunt |
|
|
12.05 – 12.25 |
Vaccines & neurological diseases |
Associate Professor Maxime Taquet |
|
|
12.25 – 12.45 |
Vaccines against meningitis |
Professor Caroline Trotter |
|
|
12.45 – 13.30 |
Lunch & Networking |
||
|
|
Session 3 –Global Health |
|
|
|
13.30 – 13.50 |
Malaria vaccines: Where are we now? |
Professor Simon Draper |
|
|
13.50 – 14.10 |
Towards the development of improved Tuberculosis vaccines |
Dr Rachel Tanner |
|
|
14.10 – 14.30 |
Neutralising Antibodies in HIV Therapy & Cure |
Professor John Frater |
|
|
14.30 – 15.10 |
Typhoid Conjugate Vaccine (TCV) role out – a fireside chat |
Professor Sir Andrew Pollard Professor Melita Gordon |
|
|
15.10 - 15.30 |
Afternoon break |
||
|
15.30 – 16.15 |
Key Note talk: Cancer immuno-prevention |
Professor Sarah Blagden |
|
|
|||
|
16.15 – 17.15 |
Controlled human infection with Neisseria lactamica induces Neisseria meningitidis-specific CD4+ T cells and nasal secretory IgA associated with colonisation density Immune determinants of mRNA vaccine non-responsiveness in immunocompromised individuals Resurgence of Measles in England: Inequalities, Vaccine Uptake, and Public Health Response Investigating the predictive power of machine learning algorithms for antigenic novelty of influenza H3 viruses A co-production study to develop tailored recruitment materials for adolescents, parents, and pregnant women to improve uptake into vaccine trials Induction of anti-SARS-CoV-2 Spike IgG4 following heterologous prime-boost COVID vaccination |
Ryan Elliott, PhD Student, University of Southampton
Dr Sam Murray, Senior Bioinformatician, University of Oxford Dr Jamil Shah Foridi, Public Health Specialist Registrar, ST2, University Hospitals Coventry and Warwickshire Lucy Greenwood, DPhil Student, University of Oxford
|
|
|
17:15 – 18:00 |
Sponsor Symposia A novel combination approach to influenza vaccination: MF59 adjuvant, cell-based production and higher antigen content than standard-dose influenza vaccines
For UK HCPs only This event has been organised and funded by CSL Seqirus.
CSL Seqirus products will be discussed.
Click here for prescribing information and Adverse event reporting details. GBR-aTIVc-26-0076 Sept 2026 |
CSL Seqirus Professor Adam Finn |
|
|
18.30 - 19.00 |
Drink’s reception |
New College |
|
|
19.00 - 20:30 |
Conference Dinner – New College |
||
Day two – Thursday 1st Oct
|
08.00 – 08.30 |
Coffee |
||
|
08.30 – 09.15 |
Sponsor Symposia Beyond the Clinical Response: Communication, Support and Collaboration in Meningococcal Disease This is a non-promotional symposium organised and funded by GSK. |
GSK Michelle Falconer, MPH, BN (Hons), RN, DN Cert Tom Nutt, CEO Meningitis Now Michelle Bresnahan, Founder A Life for a Cure |
|
|
|
Session 4 - AI & Digital transformation |
||
|
09.15 – 09.35 |
New opportunities with AI |
Professor Samir Bhatt |
|
|
09.35 – 09.55 |
From models to action: Translating epidemic analytics into pandemic |
Dr Arminder Deol |
|
|
09.55 – 10.15 |
Manufactured doubt across the life course: AI, synthetic content, & vaccine narratives |
Dr Sam Martin |
|
|
10.15-11.00 |
Keynote Talk: Mapping human immune landscapes |
Prof Helder Nakaya |
|
|
11.00 – 11.30 |
Refreshment break |
||
|
|
Session 5 - Hot topics in vaccinology (Cancer vaccinology/sexual and reproductive health vaccinology (Mpox/GC)/vaccines for respiratory infections) |
||
|
11.30 – 11.50 |
Prevention of Hepatitis B – old challenges, new strategies |
Prof Philippa Matthews |
|
|
11.50-12.10 |
Novel vaccine formulations |
Dr Anita Milicic |
|
|
12.10 – 12.30 |
Strengthening adult vaccine schedules: The role of vaccine co-administration |
Dr Eva Galiza Dr Rajeka Lazarus |
|
|
12.30- 12.50 |
Gonorrhoea Vaccines: What's Changed & What Comes next? |
Associate Professor Susanne Hodgson |
|
|
12.50 – 13.50 |
Lunch |
||
|
|
Session 6 - Global vaccine policy & delivery |
||
|
13.50 – 14.10 |
Global Vaccine Policy and implementation |
Dr Marta Tufet Bayona |
|
|
14.10 – 14.30 |
UK Vaccine Policy and implementation |
Dr Thomas Waite |
|
|
14.30 – 14.50 |
Developing a vaccine against Bundibugyo ebolavirus |
Professor Teresa Lambe |
|
| 14.50 – 15.20 | Panel Discussion: Global Vaccine Policy: Vaccines in a Changing Climate |
|
|
| 15.20 – 15.50 | Refreshment break | ||
|
15.50 – 16.05 |
Presentations & Prize giving for abstracts & Posters |
||
|
16.05-16.45 |
Dr Jenner's House Award for Exceptional Achievement in Vaccinology Prize giving and keynote lecture |
Self-amplifying RNA vaccine development Professor Robin Shattock |
|
|
16.45 – 17.00 |
Final remarks |
Dr Rebecca Sutherland Consultant in Infectious Diseases, Edinburgh University Chair of UKCVN 2027 Conference Committee |
|
Conference Venue
The conference will take place at the Life and Mind Building, University of Oxford
South Parks Road
Oxford
OX1 3EL
Optional Conference Dinner
The optional dinner on Wednesday 30th September will be held at New College Oxford.
New College,
Oxford
OX1 3BN
Accomodation
The UKCVN conference is not a residential conference but we would suggest the following websites to source accommodation:
University of Oxford College Accommodation
Map to Conference Venue
Map to Dinner Venue
Registration - Now Open
UKCVN 2026 will be held as a two-day physical meeting, with virtual participation. The Organising Committee strongly encourage attending the physical meeting if at all possible.
The in-person registration fee includes:
- all lectures & panel discussion
- ECR Poster showcase
- all refreshment breaks and lunches
- 2 x Sponsor Symposia
The registration fee does not include accommodation, travel or the conference dinner.
Standard & Nurses fess quoted are for HCPs working in medicine / research. Trainee/Student registration is for those HCP's that are still in training or completeing a MSC, DPhil, PhD. Those from industry & Media wishing to register should use commerical registration.
| Commercial Registration | £300 |
| Standard Registration | £120 |
| Trainee/Student Registration | £80 |
| 1 day Standard Registration | £65 |
| 1 day Nurse/Trainee Registration | £45 |
| Nurses | £80 |
| Conference dinner - New College | £65 |
| Online Standard registration | £130 |
| Online Nurse/trainee | £90 |
| Online registration - LMIC* | £0 |
*LMIC are defined from this list of Low- and Middle-Income Countries.
Cancellation Policy
Cancellations should be made by emailing ukcvn@paediatrics.ox.ac.uk and are subject to the terms and conditions outlined at the time of booking. A refund will be given for cancellations up until one month before the meeting, less a 10% administration charge. No refund can be given for cancellations made within one month of the meeting, nor are there refunds for no-shows.
Travel and Carer's Bursaries - now Closed
There are a limited number of bursaries available for help towards travel or childcare for in-person attendance at the UKCVN Conference.
The bursary can cover:
- Nursery fees
- Childcare fees
- Carer's costs
- Standard class train & bus fares
The bursary does not cover:
- international flights
- Mileage
- Parking
How to apply for a bursary
Please read this information carefully. If you fail to complete the process within the required timeframe, your application will not be accepted
- Complete the online application form - UKCVN Travel/Childcare Bursary Application – Fill in form
- Be sure to complete the process right to the end: you'll receive an automated email upon successful completion.
- You'll receive an email from ukcvn@paediatrics.ox.ac.uk to confirm your application is received and correct.
- The application form must be completed by midday on 31st July 2026 at the latest. There are no exceptions to this deadline.
- You will be notified of the outcome of your application in the 1st week of August 2026.
- You will also be sent information on how to claim your bursary in your outcome notification.
Abstracts - now closed
If you are joining us in-person in Oxford, you are warmly invited to share your work at the conference’s oral and poster presentation sessions by submitting an abstract for consideration.
Abstract submissions are now closed
The abstract submission deadline was 12:00 BST on 26 June 2026
Abstract Topics:
Abstract submissions are invited for oral presentations and poster display with a link to vaccine-related research or patient case presentations.
Posters
If selected for a poster presentation you will be required to display a physical poster. Physical posters will be on display in the exhibition hall for the duration of the conference.
Terms & Conditions of submission are:
- If the abstract is accepted, a presenting author must register to attend the conference.
- The submitter should ideally be the presenting author. If this is not possible the replacement presenter must be a named author on the original submission.
- Last date for abstract submission is: Friday 26th June 2026 at 12pm BST
- Authors and presenters are expected to adhere to best practice in presenting their work, ensuring that presentations are free from commercial bias and based on evidence accepted by our peers.
- All authors of abstracts are expected to declare any potential conflict of interest relevant to the presentation being given at the time of submission.
- The submitter is responsible for obtaining consent to publish the names of authors/co-authors and consent from any patients (if case reports).
- The presenting author (as indicated on the submission) will be notified of the decision of the reviewers by Friday 31st July 2026.
Currently confirmed speakers are listed blow. Additional speakers will be listed as the programme is developed. All speakers are subject to change.
| Dr Sally Frampton Humanities and Healthcare Fellow, TORCH: The Oxford Research Centre for the Humanities, Faculty of History, University of Oxford |
Profile |
| Dr Helen Campbell Lead Clinical Scientist, UKHSA Immunisation and Vaccine Preventable Diseases Division |
Profile |
| Professor Teresa Lambe Calleva Head of Vaccine Immunology, University of Oxford |
Profile |
| Assistant Professor Alex de Figueiredo IMMS Lead, Vaccine Confidence Project, London School of Hygiene & Tropical Medicine (LSHTM) |
Profile |
| Professor Dave Hunt Chair of Neuroinflammation Medicine, Institute of Genetics and Cancer, University of Edinburgh |
Profile |
| Associate Professor Maxime Taquet Specialty Registrar in Psychiatry, Oxford Health NHS Foundation Trust |
Profile |
| Professor Caroline Trotter Professor of Global Health, University of Cambridge & Professor of Infectious Disease Epidemiology, Imperial College London |
Profile |
| Associate Professor Rachel Tanner Associate Professor of One Health, Department of Biology, University of Oxford |
Profile |
| Professor Sir Andrew Pollard Ashall Professor of Infection and Immunity & Director, Oxford Vaccine Group |
Profile |
| Professor Melita Gordon AXA Chair of Vaccinology and Global Health, University of Edinburgh |
Profile |
| Professor Sarah Blagden Professor of Experimental Oncology, University of Oxford |
Profile |
| Dr Arminder Deol Head of Data Science and Advanced Analysis, CEPI (Coalition for Epidemic Preparedness Innovations) |
Profile |
| Prof Helder Nakaya Associate Professor, School of Pharmaceutical Sciences, University of São Paulo |
Profile |
| Prof Philippa Matthews Clinical Group Leader, Francis Crick Institute |
Profile |
|
Dr Eva Galiza |
Profile |
| Dr Rajeka Lazarus Consultant Senior Lecturer in Infectious Diseases and Vaccinology, University of Bristol, Honorary Consultant in Infectious Diseases and Microbiology, UK Health Security Agency |
Profile |
| Associate Professor Susanne Hodgson Physician Scientist, University of Oxford |
Profile |
| Dr Thomas Waite Deputy Chief Medical Officer for England |
Profile |
| Professor Samir Bhatt Professor of Statistics & Public Health, Imperial College London & Professor of Machine Learning & Public Health, University of Copenhagen |
Profile |
| Professor Simon Draper Professor of Vaccinology and Translational Medicine, Department of Paediatrics, University of Oxford |
Profile |
| Dr Anita Milicic Associate Professor, Vaccine Formulation & Adjuvants Group, The Jenner Institute, University of Oxford |
Profile |
| Professor John Frater Professor of Infectious Diseases, Nuffield Department of Medicine, University of Oxford |
Profile |
| Dr Marta Tufet Bayona Director of Grant Design & Partnerships, GAVI |
Profile |
| Dr Sam Martin Smart Data Research UK Fellow, Manchester Metropolitan University & Senior Research Fellow, Vaccines & Society, University of Oxford |
Profile |
| Professor Robin Shattock Professor of Mucosal Infection & Immunity, Imperial College London |
Profile |
| Professor Robin Stott Ambassador, UK Health Alliance on Climate Change |
Profile |
|
Dr Jack Saunders |
Profile |
Conference Organising Committee
See the People page for profile and contact links. For general enquiries, please e-mail ukcvn@paediatrics.ox.ac.uk
Professor Katrina Pollock, MRC Clinical Scientist in Vaccinology, University of Oxford (Chair)
Georgie Bishop, EA to Professor Lambe, Dr Aley, and Professor Katrina Pollock, Oxford Vaccine Group, University of Oxford, UK
Dr Adam Dale, Associate Professor in Infectious Diseases and Medical Microbiology, University of Southampton
Charlie Firth, Communication and Global Engagement Lead, University of Oxford
Dr Eva Galiza, Senior Clinical Research Fellow, St George’s Vaccine Institute
Associate Professor Susanne Hodgson, Consultant and Clinical Scientist, University of Oxford
Dr Rajeka Lazarus, Consultant Senior Lecturer in Infectious Diseases and Vaccinology, University of Bristol, Honorary Consultant in Infectious Diseases and Microbiology, UK Health Security Agency
Clara Lloyd, Conference & Events Manager, Oxford Vaccine Group, University of Oxford, UK
Dr Angela Minassian, Associate Professor & Honorary Consultant, University of Oxford
Dr Alice Packham, Academic Clinical Fellow in Infectious Diseases and General Internal Medicine, University of Bristol
Professor Maheshi Ramasamy, Professor of Infection & Vaccinology, University of Oxford
Dr Rebecca Sutherland, Consultant in Infectious Disease, NHS Lothian
